A "practice-changing study" presented at #ASCO20 - Pembrolizumab Merck doubles progression-free survival for certain patients with metastatic colorectal cancer, shows study from Université Sorbonne Paris Nord bit.ly/3cfOKJ5 with Perspective from Lee Schwartzberg MD West Cancer Center & Research Institute OneOncology

Welcome, Dr. John Fox! We're proud that John Fox, MD has joined OneOncology as Medical Director of Managed Care. Dr. Fox will play an integral role supporting partner practices to develop and optimize value-based care to achieve Quadruple AIM goals. oneoncology.com/blog/oneoncolo…

Welcome! Los Angeles Cancer Network is joining the OneOncology partnership connecting their 18 providers with the 470 other physicians and providers on our platform from Los Angeles to New York. oneoncology.com/blog/oneoncolo…

OneOncology and Foundation Medicine unlock the power of precision oncology with first-of-its-kind partnership. oneoncology.com/blog/oneoncolo…

This partnership means that more patients in OneOncology’s vast community network can access our genomic profiling technology and identify the insights that can inform their specific #cancer. So excited to get started!

"The cost of medications are going through the roof and if we as providers don’t embrace the few opportunities where we can bend the cost curve, we are going to bankrupt the system and that’s not good for anyone." #biosimilars #oncology managedhealthcareexecutive.com/view/oneoncolo…

Leading New Jersey oncologists form Astera Cancer Care and join the OneOncology platform, making this premier group the 9th practice to join the partnership of independent community oncologists. oneoncology.com/blog/premier-c…

OneOncology statement regarding Dr. Axel Grothey: While Dr. Grothey is not a OneOncology employee, what we’ve recently learned regarding his actions at the Mayo Clinic does not align with our values and the Code of Conduct to which we hold our employees and contractors.

We strongly condemn inappropriate workplace conduct of any nature, and as a result we are removing Dr. Grothey as medical director of OneR.

In Growth Spurt Since Joining OneOncology, The Center in Fort Worth has grown its phyisicans on staff by 60 percent in one year. hubs.li/H0S0RNy0

Dr. Schleicher, Pres, TN @OSSatACCC & Tennessee Medical Association member, describes 3 of 400 cases of patient steerage by PBMs away from TO’s pharmacy & often to a PBM-owned pharmacy leading to negative patient consequences. Cases contrast PBM reform bill the TN legislature passed last year.

Roses are red, Hospitals not free, Let’s go Congress, Reform 340B! #HealthPolicyValentines

CVS reports in its annual report that if pharma companies stop sales to multiple #340B contract pharmacies it "could materially & adversely affect the Company." CVS Health is saying that 340B is an important part of earnings. So, their profits are discounts patients don't see. ??

We're gearing up for the Community Oncology meeting. In addition to the main events, stop by Booth 313 or reach out to learn more about how OneOncology is enabling physician independence. oneoncology.com/coa/

Phil Watts at #AMCCBS: We've seen rising costs in cancer care, which puts presssure on community practices. Given these changes, practices often ask questions about remaining independent.

Phil Watts at #AMCCBS: "At the core, a lot of community oncologists are asking, how do I remain independent yet continue to provide the highest quality care and navigate a complex heathcare environment?"

Phil Watts at #AMCCBS: We've had a groups wanting to exit hosptial aggrements and looking to groups like ours with good economies of scale and capital.

It was a terrific discussion.